Grown Rogue International (GRUSF) Short-term Investments (2009 - 2025)

Grown Rogue International (GRUSF) recorded quarterly Short-term Investments of $5677.2 billion in Q3 2025, up 161507731.41% quarter-over-quarter from $3.5 million in Q2 2025.

Grown Rogue International (GRUSF) Short-term Investments (2009 - 2025) Analysis & Trends

Grown Rogue International's Short-term Investments history runs 6 years deep, the most recent figure standing at $5677.2 billion for Q3 2025.

  • In Q3 2025, Short-term Investments changed N/A year-over-year to $5677.2 billion; the TTM figure through Sep 2025 stood at $5677.2 billion (changed N/A YoY), while the FY2024 annual figure was $4855.8 billion, changed N/A from the prior year.
  • Short-term Investments was $5677.2 billion for Q3 2025 at Grown Rogue International, up from $3.5 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $5677.2 billion in Q3 2025 to a low of $2.3 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Grown Rogue International - - 3.96 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 5,677.23 Bn
Jun 30, 2025 3.52 Mn
Mar 31, 2025 2.30 Mn
Dec 31, 2024 4,855.80 Bn
Aug 31, 2015 25,899.36
May 31, 2015 -25,182.52
May 31, 2012 924,808.96
Feb 29, 2012 456,776.33
Nov 30, 2011 488,440.76
Aug 31, 2011 1.36 Mn
May 31, 2011 2.23 Mn
Aug 31, 2009 90,377.16